116 related articles for article (PubMed ID: 11151971)
1. Regulation of adhesion molecules: a new target for the treatment of chronic venous insufficiency.
Verbeuren TJ; Bouskela E; Cohen RA; Vanhoutte PM
Microcirculation; 2000; 7(6 Pt 2):S41-8. PubMed ID: 11151971
[TBL] [Abstract][Full Text] [Related]
2. Micronized purified flavonoid fraction and the treatment of chronic venous insufficiency: microcirculatory mechanisms.
Smith PD
Microcirculation; 2000; 7(6 Pt 2):S35-40. PubMed ID: 11151970
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic management of chronic venous insufficiency: microcirculation as a target.
Bergan JJ; Schmid-Schönbein GW
Microcirculation; 2000; 7(6 Pt 2):S23-8. PubMed ID: 11151967
[TBL] [Abstract][Full Text] [Related]
4. Deleterious effects of white cells in the course of skin damage in CVI.
Coleridge Smith PD
Int Angiol; 2002 Jun; 21(2 Suppl 1):26-32. PubMed ID: 12515977
[TBL] [Abstract][Full Text] [Related]
5. Biological properties of flavonoids pertaining to inflammation.
Manthey JA
Microcirculation; 2000; 7(6 Pt 2):S29-34. PubMed ID: 11151968
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated L-selectin expression on lymphocytes in patients with chronic venous insufficiency.
Jünger M; Friedrich B; Hahn J; Klyscz T; Müller CA; Schmid-Schönbein GW
Clin Hemorheol Microcirc; 2001; 25(1):21-30. PubMed ID: 11790867
[TBL] [Abstract][Full Text] [Related]
7. Experimental models to investigate inflammatory processes in chronic venous insufficiency.
Korthuis RJ; Unthank JL
Microcirculation; 2000; 7(6 Pt 2):S13-22. PubMed ID: 11151966
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiological mechanisms of lower limb chronic venous insufficiency and possibility of its correction with Antistax].
Stoĭko IuM; Gudymovich VG
Angiol Sosud Khir; 2006; 12(3):77-82. PubMed ID: 17641618
[TBL] [Abstract][Full Text] [Related]
9. [What do the phlebologist and the subject suffering from phlebologic disease think about a new therapeutic agent. Treatment of venous and microcirculatory stasis using Daflon. Apropos of 76 cases].
Itailau R
Phlebologie; 1974; 27(3):375-9. PubMed ID: 4445267
[No Abstract] [Full Text] [Related]
10. Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot study.
Shoab SS; Porter JB; Scurr JH; Coleridge-Smith PD
J Vasc Surg; 2000 Mar; 31(3):456-61. PubMed ID: 10709057
[TBL] [Abstract][Full Text] [Related]
11. Microcirculatory inflammation in chronic venous insufficiency: current status and future directions.
Durán W; Pappas PJ; Schmid-Schönbein GW
Microcirculation; 2000; 7(6 Pt 2):S49-58. PubMed ID: 11151972
[TBL] [Abstract][Full Text] [Related]
12. Dermal pathology, cellular biology, and inflammation in chronic venous disease.
Raffetto JD
Thromb Res; 2009; 123 Suppl 4():S66-71. PubMed ID: 19303508
[TBL] [Abstract][Full Text] [Related]
13. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan.
Abu-Taha M; Rius C; Hermenegildo C; Noguera I; Cerda-Nicolas JM; Issekutz AC; Jose PJ; Cortijo J; Morcillo EJ; Sanz MJ
J Immunol; 2009 Jul; 183(2):1393-402. PubMed ID: 19553526
[TBL] [Abstract][Full Text] [Related]
14. Microcirculatory effects of Viatromb spray gel heparin in chronic venous insufficiency: evaluation of TcPO2 and PCO2--a product evaluation study.
Rosaria Cesarone M; Belcaro G; Errichi S; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
Angiology; 2007; 58 Suppl 1():21S-26S. PubMed ID: 17478879
[TBL] [Abstract][Full Text] [Related]
15. Rapid relief of signs/symptoms in chronic venous microangiopathy with pycnogenol: a prospective, controlled study.
Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
Angiology; 2006; 57(5):569-76. PubMed ID: 17067979
[TBL] [Abstract][Full Text] [Related]
16. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
Iablokov EG; Bogachev VIu; Domoradskaia AI
Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954
[TBL] [Abstract][Full Text] [Related]
17. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.
Seguí J; Gironella M; Sans M; Granell S; Gil F; Gimeno M; Coronel P; Piqué JM; Panés J
J Leukoc Biol; 2004 Sep; 76(3):537-44. PubMed ID: 15197232
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological targets of drugs employed in chronic venous and lymphatic insufficiency.
Boisseau MR
Int Angiol; 2002 Jun; 21(2 Suppl 1):33-9. PubMed ID: 12515978
[TBL] [Abstract][Full Text] [Related]
19. [Role of leukocytes in the pathogenesis of trophic venous disorders].
Carpentier PH
J Mal Vasc; 1998 Oct; 23(4):274-6. PubMed ID: 9827407
[TBL] [Abstract][Full Text] [Related]
20. Hydralazine reduces leukocyte migration through different mechanisms in spontaneously hypertensive and normotensive rats.
Rodrigues SF; de Oliveira MA; dos Santos RA; Soares AG; de Cássia Tostes R; Carvalho MH; Fortes ZB
Eur J Pharmacol; 2008 Jul; 589(1-3):206-14. PubMed ID: 18554582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
